UBS Maintains Buy on Alvotech, Lowers Price Target to $6

Benzinga Newsdesk www.benzinga.com Negative 64.1%

Neg 64.1% Neu 0% Pos 0%

UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $10 to $6.

Comments

No comments yet. Be the first!